US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 1.9000
  • -0.0750-3.80%
Close Jan 17 16:00 ET
33.35MMarket Cap-3.80P/E (TTM)

Lexaria Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-130.70%-2.73M
15.68%-4.96M
-16.65%-1.89M
29.11%-1.27M
49.55%-619.61K
5.11%-1.18M
-20.53%-5.88M
-37.83%-1.62M
-41.84%-1.79M
3.84%-1.23M
Net income from continuing operations
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
33.02%-1.19M
9.09%-6.71M
17.46%-1.25M
1.44%-2.38M
9.53%-1.31M
Depreciation and amortization
15.35%33.2K
-47.62%76.15K
-110.94%-7.76K
56.75%39.2K
-35.58%15.93K
16.37%28.78K
41.55%145.4K
186.79%70.93K
4.68%25.01K
-5.48%24.73K
Other non cash items
-90.73%184
-10.31%39.28K
208.49%33.77K
-214.13%-14.79K
-9.12%18.3K
878.43%1.99K
-96.48%43.79K
-98.21%10.95K
-95.83%12.96K
-93.52%20.14K
Change In working capital
-24.97%-168.14K
-25.62%106.56K
124.36%174.13K
-84.10%76.32K
-137.46%-9.35K
-138.10%-134.55K
140.76%143.26K
-53.81%-714.85K
181.14%480.04K
123.36%24.96K
-Change in receivables
73.18%-109.45K
-290.54%-50.57K
1,660.55%46.21K
451.00%124.56K
24.87%186.71K
-382.68%-408.05K
119.30%26.54K
93.69%-2.96K
-148.19%-35.49K
431.47%149.53K
-Change in inventory
----
--0
--0
--0
----
----
2,276.30%43.07K
--0
216.44%9.36K
171.71%2.92K
-Change in prepaid assets
79.43%743.7K
-2,238.35%-641.03K
-1,074.33%-808.27K
63.65%-112.75K
-126.98%-134.49K
30.99%414.47K
111.64%29.98K
119.78%82.96K
-579.71%-310.15K
-488.21%-59.25K
-Change in payables and accrued expense
-465.66%-797.42K
833.95%826.47K
219.65%937.62K
-91.19%73.47K
16.24%-43.65K
-255.87%-140.97K
94.48%88.49K
-13,829.01%-783.65K
1,959.61%833.81K
28.56%-52.12K
-Change in other current liabilities
----
25.75%-33.27K
42.95%-6.39K
32.20%-8.96K
----
----
---44.81K
---11.2K
---13.21K
----
-Change in other working capital
---4.96K
--4.96K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-130.70%-2.73M
15.68%-4.96M
-16.65%-1.89M
29.11%-1.27M
49.55%-619.61K
5.11%-1.18M
-20.53%-5.88M
-37.83%-1.62M
-41.84%-1.79M
3.84%-1.23M
Investing cash flow
Cash flow from continuing investing activities
5.55%-37.8K
-11.20%-188.61K
-1.68%-69.59K
34.61%-22K
-74.37%-56.99K
-14.88%-40.03K
6.11%-169.61K
-36.75%-68.44K
11.35%-33.65K
5.05%-32.68K
Net PPE purchase and sale
---24.65K
-27.46%-43.01K
---43.01K
--0
--0
--0
31.40%-33.75K
--0
--0
---13.25K
Net intangibles purchase and sale
67.12%-13.16K
-7.16%-145.59K
61.17%-26.57K
34.61%-22K
-193.22%-56.99K
-179.08%-40.03K
-3.36%-135.86K
-36.76%-68.44K
-8.04%-33.65K
43.54%-19.44K
Cash from discontinued investing activities
Investing cash flow
5.55%-37.8K
-11.20%-188.61K
-1.68%-69.59K
34.61%-22K
-74.37%-56.99K
-14.88%-40.03K
6.11%-169.61K
-36.75%-68.44K
11.35%-33.65K
5.05%-32.68K
Financing cash flow
Cash flow from continuing financing activities
138.84%4.35M
548.86%10.32M
0
194.67%5.04M
3.45M
1.82M
3,664.42%1.59M
-986.01%-121.69K
15,375.06%1.71M
0
Net common stock issuance
248.27%4.35M
164.74%4.21M
--0
--0
--2.96M
--1.25M
--1.59M
---121.69K
--1.71M
--0
Proceeds from stock option exercised by employees
--0
--6.11M
--0
--5.04M
--491.82K
--571.65K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
138.84%4.35M
548.86%10.32M
--0
194.67%5.04M
--3.45M
--1.82M
3,664.42%1.59M
-986.01%-121.69K
15,375.06%1.71M
--0
Net cash flow
Beginning cash position
380.72%6.5M
-76.74%1.35M
167.36%8.46M
43.80%4.71M
-56.89%1.95M
-76.74%1.35M
-46.75%5.81M
-55.13%3.16M
-60.86%3.27M
-53.18%4.53M
Current changes in cash
164.61%1.58M
215.84%5.17M
-8.25%-1.96M
3,570.48%3.75M
320.17%2.78M
146.69%597.69K
12.61%-4.46M
-46.37%-1.81M
91.73%-108.2K
4.68%-1.26M
Effect of exchange rate changes
-172.62%-3.18K
---19.82K
--2.05K
---1.24K
---25K
--4.37K
--0
--0
----
----
End cash Position
313.39%8.08M
380.72%6.5M
380.72%6.5M
167.36%8.46M
43.80%4.71M
-56.89%1.95M
-76.74%1.35M
-76.74%1.35M
-55.13%3.16M
-60.86%3.27M
Free cash flow
-126.23%-2.76M
14.93%-5.15M
-16.04%-1.96M
29.21%-1.29M
46.34%-676.6K
4.57%-1.22M
-19.58%-6.05M
-37.78%-1.69M
-40.28%-1.82M
3.87%-1.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -130.70%-2.73M15.68%-4.96M-16.65%-1.89M29.11%-1.27M49.55%-619.61K5.11%-1.18M-20.53%-5.88M-37.83%-1.62M-41.84%-1.79M3.84%-1.23M
Net income from continuing operations -128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K33.02%-1.19M9.09%-6.71M17.46%-1.25M1.44%-2.38M9.53%-1.31M
Depreciation and amortization 15.35%33.2K-47.62%76.15K-110.94%-7.76K56.75%39.2K-35.58%15.93K16.37%28.78K41.55%145.4K186.79%70.93K4.68%25.01K-5.48%24.73K
Other non cash items -90.73%184-10.31%39.28K208.49%33.77K-214.13%-14.79K-9.12%18.3K878.43%1.99K-96.48%43.79K-98.21%10.95K-95.83%12.96K-93.52%20.14K
Change In working capital -24.97%-168.14K-25.62%106.56K124.36%174.13K-84.10%76.32K-137.46%-9.35K-138.10%-134.55K140.76%143.26K-53.81%-714.85K181.14%480.04K123.36%24.96K
-Change in receivables 73.18%-109.45K-290.54%-50.57K1,660.55%46.21K451.00%124.56K24.87%186.71K-382.68%-408.05K119.30%26.54K93.69%-2.96K-148.19%-35.49K431.47%149.53K
-Change in inventory ------0--0--0--------2,276.30%43.07K--0216.44%9.36K171.71%2.92K
-Change in prepaid assets 79.43%743.7K-2,238.35%-641.03K-1,074.33%-808.27K63.65%-112.75K-126.98%-134.49K30.99%414.47K111.64%29.98K119.78%82.96K-579.71%-310.15K-488.21%-59.25K
-Change in payables and accrued expense -465.66%-797.42K833.95%826.47K219.65%937.62K-91.19%73.47K16.24%-43.65K-255.87%-140.97K94.48%88.49K-13,829.01%-783.65K1,959.61%833.81K28.56%-52.12K
-Change in other current liabilities ----25.75%-33.27K42.95%-6.39K32.20%-8.96K-----------44.81K---11.2K---13.21K----
-Change in other working capital ---4.96K--4.96K--------------------------------
Cash from discontinued investing activities
Operating cash flow -130.70%-2.73M15.68%-4.96M-16.65%-1.89M29.11%-1.27M49.55%-619.61K5.11%-1.18M-20.53%-5.88M-37.83%-1.62M-41.84%-1.79M3.84%-1.23M
Investing cash flow
Cash flow from continuing investing activities 5.55%-37.8K-11.20%-188.61K-1.68%-69.59K34.61%-22K-74.37%-56.99K-14.88%-40.03K6.11%-169.61K-36.75%-68.44K11.35%-33.65K5.05%-32.68K
Net PPE purchase and sale ---24.65K-27.46%-43.01K---43.01K--0--0--031.40%-33.75K--0--0---13.25K
Net intangibles purchase and sale 67.12%-13.16K-7.16%-145.59K61.17%-26.57K34.61%-22K-193.22%-56.99K-179.08%-40.03K-3.36%-135.86K-36.76%-68.44K-8.04%-33.65K43.54%-19.44K
Cash from discontinued investing activities
Investing cash flow 5.55%-37.8K-11.20%-188.61K-1.68%-69.59K34.61%-22K-74.37%-56.99K-14.88%-40.03K6.11%-169.61K-36.75%-68.44K11.35%-33.65K5.05%-32.68K
Financing cash flow
Cash flow from continuing financing activities 138.84%4.35M548.86%10.32M0194.67%5.04M3.45M1.82M3,664.42%1.59M-986.01%-121.69K15,375.06%1.71M0
Net common stock issuance 248.27%4.35M164.74%4.21M--0--0--2.96M--1.25M--1.59M---121.69K--1.71M--0
Proceeds from stock option exercised by employees --0--6.11M--0--5.04M--491.82K--571.65K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 138.84%4.35M548.86%10.32M--0194.67%5.04M--3.45M--1.82M3,664.42%1.59M-986.01%-121.69K15,375.06%1.71M--0
Net cash flow
Beginning cash position 380.72%6.5M-76.74%1.35M167.36%8.46M43.80%4.71M-56.89%1.95M-76.74%1.35M-46.75%5.81M-55.13%3.16M-60.86%3.27M-53.18%4.53M
Current changes in cash 164.61%1.58M215.84%5.17M-8.25%-1.96M3,570.48%3.75M320.17%2.78M146.69%597.69K12.61%-4.46M-46.37%-1.81M91.73%-108.2K4.68%-1.26M
Effect of exchange rate changes -172.62%-3.18K---19.82K--2.05K---1.24K---25K--4.37K--0--0--------
End cash Position 313.39%8.08M380.72%6.5M380.72%6.5M167.36%8.46M43.80%4.71M-56.89%1.95M-76.74%1.35M-76.74%1.35M-55.13%3.16M-60.86%3.27M
Free cash flow -126.23%-2.76M14.93%-5.15M-16.04%-1.96M29.21%-1.29M46.34%-676.6K4.57%-1.22M-19.58%-6.05M-37.78%-1.69M-40.28%-1.82M3.87%-1.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+3.50%
Alibaba
BABA
+3.26%
NVIDIA
NVDA
+3.10%
Tesla
TSLA
+3.06%
Advanced Micro Devices
AMD
+2.55%

Unlock the Full List